Hudson Alakonya is a Rhodes Scholar currently studying his PhD in Oncology at the University of Oxford, where he is developing molecular imaging agents for early diagnosis and prognosis evaluation of pancreatic ductal adenocarcinoma. He is a lead founder member of the organisation and oversees its overall leadership and management. He completed his MSc in Cancer at the University College London and BSc in Industrial Microbiology and Biotechnology at the Technical University of Mombasa.